Edwards Lifesciences Corporation 4.3% 15-JUN-2028Edwards Lifesciences Corporation 4.3% 15-JUN-2028Edwards Lifesciences Corporation 4.3% 15-JUN-2028

Edwards Lifesciences Corporation 4.3% 15-JUN-2028

Key terms


Outstanding amount
‪600.00 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
4.30%
Coupon frequency
Semi-annual
Maturity date
Jun 15, 2028
Term to maturity
1 year

Details


Sector
Health Technology
Industry
Medical Specialties
Home page
Issue date
Jun 15, 2018
ISIN
US28176EAD04
CUSIP
28176EAD0
FIGI
BBG00L3D8KL5
Identifiers
ISIN US28176EAD04
CFI code
DTFNGR
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.